Connexins in endothelial barrier function – novel therapeutic targets countering vascular hyperpermeability

Summary

Prolonged vascular hyperpermeability is a common feature of many diseases. Vascular hyperpermeability is typically associated with changes in the expression patterns of adherens and tight junction proteins. Here, we focus on the less-appreciated contribution of gap junction proteins (connexins) to basal vascular permeability and endothelial dysfunction. First, we assess the association of connexins with endothelial barrier integrity by introducing tools used in connexin biology and relating the findings to customary readouts in vascular biology. Second, we explore potential mechanistic ties between connexins and junction regulation. Third, we review the role of connexins in microvascular organisation and development, focusing on interactions of the endothelium with mural cells and tissue-specific perivascular cells. Last, we see how connexins contribute to the interactions between the endothelium and components of the immune system, by using neutrophils as an example. Mounting evidence of crosstalk between connexins and other junction proteins suggests that we rethink the way in which different junction components contribute to endothelial barrier function. Given the multiple points of connexin-mediated communication arising from the endothelium, there is great potential for synergism between connexin-targeted inhibitors and existing immune-targeted therapeutics. As more drugs targeting connexins progress through clinical trials, it is hoped that some might prove effective at countering vascular hyperpermeability.

Keywords

Connexins - endothelial cells - gap junctions - permeability

• References

• 1 Goddard LM. et al. Cellular and molecular regulation of vascular permeability. Thromb Haemost 2013; 109: 407-415.
• 2 Chavez A. et al. New insights into the regulation of vascular permeability. Int Rev Cell Mol Biol 2011; 290: 205-248.
• 3 Aghajanian A. et al. Endothelial cell junctions and the regulation of vascular permeability and leukocyte transmigration. J Thromb Haemost 2008; 06: 1453-1460.
• 4 Dejana E. et al. Organisation and signaling of endothelial cell-to-cell junctions in various regions of the blood and lymphatic vascular trees. Cell Tissue Res 2009; 335: 17-25.
• 5 Darwish I, Liles WC. Emerging therapeutic strategies to prevent infection-related microvascular endothelial activation and dysfunction. Virulence 2013; 04: 572-582.
• 6 García-Ponce A. et al. The role of actin-binding proteins in the control of endothelial barrier integrity. Thromb Haemost 2015; 113: 20-36.
• 7 Bazzoni G, Dejana E. Endothelial cell-to-cell junctions: molecular organisation and role in vascular homeostasis. Physiol Rev 2004; 84: 869-901.
• 8 Weber PA. et al. The permeability of gap junction channels to probes of different size is dependent on connexin composition and permeant-pore affinities. Biophys J 2004; 87: 958-973.
• 9 Zhou JZ, Jiang JX. Gap junction and hemichannel-independent actions of connexins on cell and tissue functions - An update. FEBS Lett 2014; 588: 1186-1192.
• 10 Solan JL, Lampe PD. Specific Cx43 phosphorylation events regulate gap junction turnover in vivo. FEBS Lett 2014; 588: 1423-1429.
• 11 Hervé J-C. et al. Gap junctional channels are parts of multiprotein complexes. Biochim Biophys Acta 2012; 1818: 1844-1865.
• 12 Johnstone S. et al. Biological and Biophysical Properties of Vascular Connexin Channels. Int Rev Cell Mol Biol 2009; 278: 69-118.
• 13 Koval M. et al. Mix and match: investigating heteromeric and heterotypic gap junction channels in model systems and native tissues. FEBS Lett 2014; 588: 1193-1204.
• 14 Ebong EE, Depaola N. Specificity in the participation of connexin proteins in flow-induced endothelial gap junction communication. Pflugers Arch 2013; 465: 1293-1302.
• 15 de Wit C. et al. Impaired conduction of vasodilation along arterioles in conne-xin40-deficient mice. Circ Res 2000; 86: 649-655.
• 16 Pfenniger A. et al. Shear stress modulates the expression of the atheroprotective protein Cx37 in endothelial cells. J Mol Cell Cardiol 2012; 53: 299-309.
• 17 Kwak BR. et al. Shear stress and cyclic circumferential stretch, but not pressure, alter connexin43 expression in endothelial cells. Cell Commun Adhes 2005; 12: 261-270.
• 18 Gabriels JE, Paul DL. Connexin43 is highly localized to sites of disturbed flow in rat aortic endothelium but connexin37 and connexin40 are more uniformly distributed. Circ Res 1998; 83: 636-643.
• 19 Morel S. Multiple roles of connexins in atherosclerosis- and restenosis-induced vascular remodelling. J Vasc Res 2014; 51: 149-161.
• 20 Pfenniger A. et al. Connexins in atherosclerosis. Biochim Biophys Acta 2013; 1828: 157-166.
• 21 Inai T, Shibata Y. Heterogeneous expression of endothelial connexin (Cx) 37, Cx40, and Cx43 in rat large veins. Anat Sci Int 2009; 84: 237-245.
• 22 Okamoto T, Akiyama M, Takeda M. et al. Connexin32 is expressed in vascular endothelial cells and participates in gap-junction intercellular communication. Biochem Biophys Res Commun 2009; 382: 264-268.
• 23 Meens MJ. et al. Connexins in lymphatic vessel physiology and disease. FEBS Lett 2014; 588: 1271-1277.
• 24 Wang H-H. et al. Reduction of connexin43 in human endothelial progenitor cells impairs the angiogenic potential. Angiogenesis 2013; 16: 553-560.
• 25 Cronin M. et al. Blocking connexin43 expression reduces inflammation and improves functional recovery after spinal cord injury. Mol Cell Neurosci 2008; 39: 152-160.
• 26 De Bock M. et al. Connexin channels provide a target to manipulate brain endothelial calcium dynamics and blood-brain barrier permeability. J Cereb Blood Flow Metab 2011; 31: 1942-1957.
• 27 Danesh-Meyer HV. et al. Connexin43 antisense oligodeoxynucleotide treatment down-regulates the inflammatory response in an in vitro interphase organo-typic culture model of optic nerve ischaemia. J Clin Neurosci 2008; 15: 1253-1263.
• 28 Bauer H-C. et al. ‘You Shall Not Pass’-tight junctions of the blood brain barrier. Front Neurosci 2014; 08: 392.
• 29 Nagasawa K. et al. Possible involvement of gap junctions in the barrier function of tight junctions of brain and lung endothelial cells. J Cell Physiol 2006; 208: 123-132.
• 30 Tien T. et al. Effects of High Glucose-Induced Cx43 Downregulation on Occludin and ZO-1 Expression and Tight Junction Barrier Function in Retinal Endothelial Cells. Invest Ophthalmol Vis Sci 2013; 54: 6518-6525.
• 31 Vandamme W. et al. Tumour necrosis factor alpha inhibits purinergic calcium signalling in blood-brain barrier endothelial cells. J Neurochem 2004; 88: 411-421.
• 32 Evans WH, Leybaert L. Mimetic peptides as blockers of connexin channel-facilitated intercellular communication. Cell Commun Adhes 2007; 14: 265-273.
• 33 Braet K. et al. Photoliberating inositol-1,4,5-trisphosphate triggers ATP release that is blocked by the connexin mimetic peptide gap 26. Cell Calcium 2003; 33: 37-48.
• 34 Zhang J. et al. Connexin hemichannel induced vascular leak suggests a new paradigm for cancer therapy. FEBS Lett 2014; 588: 1365-1371.
• 35 Aird WC. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 2007; 100: 158-173.
• 36 Zhang J. et al. Gap junction channel modulates pulmonary vascular permeability through calcium in acute lung injury: an experimental study. Respiration 2010; 80: 236-245.
• 37 O’Donnell JJ. et al. Gap junction protein connexin43 exacerbates lung vascular permeability. PLoS ONE 2014; 09: e100931.
• 38 Hervé J-C. et al. The connexin turnover, an important modulating factor of the level of cell-to-cell junctional communication: comparison with other integral membrane proteins. J Membr Biol 2007; 217: 21-33.
• 39 Shore EM, Nelson WJ. Biosynthesis of the Cell-Adhesion Molecule Uvomorulin (E-Cadherin) in Madin-Darby Canine Kidney Epithelial-Cells. J Biol Chem 1991; 266: 19672-19680.
• 40 Paradies NE, Grunwald GB. Purification and Characterisation of Ncad90, a Soluble Endogenous Form of N-Cadherin, Which Is Generated by Proteolysis During Retinal Development and Retains Adhesive and Neurite-Promoting Function. J Neurosci Res 1993; 36: 33-45.
• 41 Chen YH. et al. Restoration of tight junction structure and barrier function by down-regulation of the mitogen-activated protein kinase pathway in ras-transformed Madin-Darby canine kidney cells. Mol Biol Cell 2000; 11: 849-862.
• 42 Pointis G, Segretain D. Role of connexin-based gap junction channels in testis. Trends Endocrinol Metab 2005; 16: 300-306.
• 43 Carette D. et al. Major involvement of connexin 43 in seminiferous epithelial junction dynamics and male fertility. Dev Biol 2010; 346: 54-67.
• 44 Li MWM. et al. Connexin 43 is critical to maintain the homeostasis of the blood-testis barrier via its effects on tight junction reassembly. Proc Natl Acad Sci USA 2010; 107: 17998-8003.
• 45 Laird DW. Life cycle of connexins in health and disease. Biochem J 2006; 394: 527-543.
• 46 Derangeon M. et al. Reciprocal influence of connexins and apical junction proteins on their expressions and functions. Biochim Biophys Acta 2009; 1788: 768-778.
• 47 Keane RW. et al. Neural Differentiation, Ncam-Mediated Adhesion, and Gap Junctional Communication in Neuroectoderm - a Study Invitro. J Cell Biol 1988; 106: 1307-1319.
• 48 Xu X. et al. Modulation of mouse neural crest cell motility by N-cadherin and connexin 43 gap junctions. J Cell Biol 2001; 154: 217-230.
• 49 Hertig CM. et al. N-cadherin in adult rat cardiomyocytes in culture. II. Spatiotemporal appearance of proteins involved in cell-cell contact and communication. Formation of two distinct N-cadherin/catenin complexes. J Cell Sci 1996; 109: 11-20.
• 50 Luo Y, Radice GL. Cadherin-mediated adhesion is essential for myofibril continuity across the plasma membrane but not for assembly of the contractile apparatus. J Cell Sci 2003; 116: 1471-1479.
• 51 Wei C-J. et al. Connexin43 associated with an N-cadherin-containing multiprotein complex is required for gap junction formation in NIH3T3 cells. J Biol Chem 2005; 280: 19925-19936.
• 52 Giannotta M. et al. VE-cadherin and endothelial adherens junctions: active guardians of vascular integrity. Dev Cell 2013; 26: 441-454.
• 53 Vestweber D. VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscl Thromb Vasc Biol 2008; 28: 223-232.
• 54 Navarro P. et al. Differential localisation of VE- and N-cadherins in human endothelial cells: VE-cadherin competes with N-cadherin for junctional localisation. J Cell Biol 1998; 140: 1475-1484.
• 55 Luo Y, Radice GL. N-cadherin acts upstream of VE-cadherin in controlling vascular morphogenesis. J Cell Biol 2005; 169: 29-34.
• 56 Gentil-dit-Maurin A. et al. Unraveling the distinct distributions of VE- and N-cadherins in endothelial cells: A key role for p120-catenin. Exp Cell Res 2010; 316: 2587-2599.
• 57 Hatanaka K. et al. Phosphorylation of VE-cadherin controls endothelial phenotypes via p120-catenin coupling and Rac1 activation. Am J Physiol Heart Circ Physiol 2011; 300: H162-172.
• 58 Ofori-Acquah SF. et al. Heterogeneity of barrier function in the lung reflects diversity in endothelial cell junctions. Microvasc Res 2008; 75: 391-402.
• 59 Katsuno T. et al. Deficiency of zonula occludens-1 causes embryonic lethal phenotype associated with defected yolk sac angiogenesis and apoptosis of embryonic cells. Mol Biol Cell 2008; 19: 2465-2475.
• 60 Fanning AS, Anderson JM. Zonula occludens-1 and -2 are cytosolic scaffolds that regulate the assembly of cellular junctions. Ann NY Acad Sci 2009; 1165: 113-120.
• 61 Tornavaca O. et al. ZO-1 controls endothelial adherens junctions, cell-cell tension, angiogenesis, and barrier formation. J Cell Biol 2015; 208: 821-838.
• 62 Hervé J-C. et al. Influence of the scaffolding protein Zonula Occludens (ZOs) on membrane channels. Biochim Biophys Acta 2014; 1838: 595-604.
• 63 Palatinus JA. et al. ZO-1 determines adherens and gap junction localisation at intercalated disks. Am J Physiol Heart Circ Physiol 2011; 300: H583-594.
• 64 Mendoza-Naranjo A. et al. Targeting Cx43 and N-cadherin, which are abnormally upregulated in venous leg ulcers, influences migration, adhesion and activation of Rho GTPases. PLoS ONE 2012; 07: e37374.
• 65 Chen C-H. et al. The Connexin 43/ZO-1 Complex Regulates Cerebral endothelial F-actin Architecture and Migration. AJP: Cell Physiology 2015; 309: C600-607.
• 66 Shav D. et al. Wall shear stress effects on endothelial-endothelial and endothelial-smooth muscle cell interactions in tissue engineered models of the vascular wall. PLoS ONE 2014; 09: e88304.
• 67 de Wit C, Griffith TM. Connexins and gap junctions in the EDHF phenomenon and conducted vasomotor responses. Pflugers Arch 2010; 459: 897-914.
• 68 Sandow SL. et al. Involvement of myoendothelial gap junctions in the actions of endothelium-derived hyperpolarising factor. Circ Res 2002; 90: 1108-1113.
• 69 Isakson BE, Duling BR. Heterocellular contact at the myoendothelial junction influences gap junction organisation. Circ Res 2005; 97: 44-51.
• 70 Isakson BE. et al. Incidence of protein on actin bridges between endothelium and smooth muscle in arterioles demonstrates heterogeneous connexin expression and phosphorylation. Am J Physiol Heart Circ Physiol 2008; 294: H2898-2904.
• 71 Kurzen H. et al. Tightening of endothelial cell contacts: a physiologic response to cocultures with smooth-muscle-like 10T1/2 cells. J Invest Dermatol 2002; 119: 143-153.
• 72 Hirschi KK. et al. PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol 1998; 141: 805-814.
• 73 Hirschi KK. et al. Gap junction communication mediates transforming growth factor-beta activation and endothelial-induced mural cell differentiation. Circ Res 2003; 93: 429-437.
• 74 Lan Y, Liu B, Yao H. et al. Essential role of endothelial Smad4 in vascular remodelling and integrity. Mol Cell Biol 2007; 27: 7683-7692.
• 75 Armulik A. et al. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 2011; 21: 193-215.
• 76 Mathiisen TM. et al. The perivascular astroglial sheath provides a complete covering of the brain microvessels: an electron microscopic 3D reconstruction. Glia 2010; 58: 1094-1103.
• 77 Simard M. et al. Signaling at the gliovascular interface. J Neurosci 2003; 23: 9254-9262.
• 78 Danesh-Meyer HV. et al. Connexin43 mimetic peptide reduces vascular leak and retinal ganglion cell death following retinal ischaemia. Brain 2012; 135: 506-520.
• 79 Ormonde S. et al. Regulation of connexin43 gap junction protein triggers vascular recovery and healing in human ocular persistent epithelial defect wounds. J Membr Biol 2012; 245: 381-388.
• 80 Tien T. et al. Downregulation of Connexin 43 promotes vascular cell loss and excess permeability associated with the development of vascular lesions in the diabetic retina. Mol Vis 2014; 20: 732-741.
• 81 Fernandes R. et al. High glucose down-regulates intercellular communication in retinal endothelial cells by enhancing degradation of connexin 43 by a protea-some-dependent mechanism. J Biol Chem 2004; 279: 27219-27224.
• 82 Li A-F, Roy S. High glucose-induced downregulation of connexin 43 expression promotes apoptosis in microvascular endothelial cells. Invest Ophthalmol Vis Sci 2009; 50: 1400-1407.
• 83 Muto T. et al. High Glucose Alters Cx43 Expression and Gap Junction Intercellular Communication in Retinal Müller Cells: Promotes Müller Cell and Pericyte Apoptosis. Invest Ophthalmol Vis Sci 2014; 55: 4327-4337.
• 84 Nagy JA, Benjamin L, Zeng H. et al. Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis 2008; 11: 109-119.
• 85 Koval M. et al. Spontaneous Lung Dysfunction and Fibrosis in Mice Lacking Connexin 40 and Endothelial Cell Connexin 43. Am J Pathol 2011; 178: 2536-2546.
• 86 Rignault S. et al. Acute inflammation decreases the expression of connexin 40 in mouse lung. Shock 2007; 28: 78-85.
• 87 Parthasarathi K. et al. Connexin 43 mediates spread of Ca2+-dependent proin-flammatory responses in lung capillaries. J Clin Invest 2006; 116: 2193-2200.
• 88 Oviedo-Orta E, Howard Evans W. Gap junctions and connexin-mediated communication in the immune system. Biochim Biophys Acta 2004; 1662: 102-112.
• 89 Neijssen J. et al. Gap junction-mediated intercellular communication in the immune system. Prog Biophys Mol Biol 2007; 94: 207-218.
• 90 Scheckenbach KEL. et al. Connexin Channel-Dependent Signaling Pathways in Inflammation. J Vasc Res 2011; 48: 91-103.
• 91 Sáez PJ. et al. Regulation of hemichannels and gap junction channels by cytokines in antigen-presenting cells. Mediators Inflamm 2014; 2014: 742734.
• 92 Rodrigues SF, Granger DN. Blood cells and endothelial barrier function. Tissue Barriers 2015; 03: e978720.
• 93 Mayadas TN. et al. The multifaceted functions of neutrophils. Annu Rev Pathol 2014; 09: 181-218.
• 94 Hernandez LA. et al. Role of neutrophils in ischemia-reperfusion-induced microvascular injury. Am J Physiol 1987; 253: H699-703.
• 95 Carden DL. et al. Neutrophil-mediated microvascular dysfunction in postischemic canine skeletal muscle. Role of granulocyte adherence. Circ Res 1990; 66: 1436-1444.
• 96 Oliver MG. et al. Morphologic assessment of leukocyte-endothelial cell interactions in mesenteric venules subjected to ischemia and reperfusion. Inflammation 1991; 15: 331-346.
• 97 Lewis RE. et al. Acute microvascular effects of the chemotactic peptide N-for-myl-methionyl-leucyl-phenylalanine: comparisons with leukotriene B4. Microvasc Res 1989; 37: 53-69.
• 98 He P. Leucocyte/endothelium interactions and microvessel permeability: coupled or uncoupled?. Cardiovasc Res 2010; 87: 281-290.
• 99 Zahler S. et al. Gap-junctional coupling between neutrophils and endothelial cells: a novel modulator of transendothelial migration. J Leukoc Biol 2003; 73: 118-126.
• 100 Brañes MC. et al. Activation of human polymorphonuclear cells induces formation of functional gap junctions and expression of connexins. Med Sci Monit 2002; 08: BR313-323.
• 101 Scerri I. et al. Gap junctional communication does not contribute to the interaction between neutrophils and airway epithelial cells. Cell Commun Adhes 2006; 13: 1-12.
• 102 Sarieddine MZR. et al. Connexin43 modulates neutrophil recruitment to the lung. J Cell Mol Med 2009; 13: 4560-4570.
• 103 van Rijen HV. et al. Tumour necrosis factor alpha alters the expression of connexin43, connexin40, and connexin37 in human umbilical vein endothelial cells. Cytokine 1998; 10: 258-264.
• 104 Mattila P. et al. TNF alpha-induced expression of endothelial adhesion molecules, ICAM-1 and VCAM-1, is linked to protein kinase C activation. Scand J Immunol 1992; 36: 159-165.
• 105 Ferro TJ. et al. Tumor necrosis factor-alpha activates pulmonary artery endothelial protein kinase C. Am J Physiol 1993; 264: L7-14.
• 106 Nielsen MS. et al. Gap Junctions. Compr Physiol 2012; 02: 1981-2035.
• 107 Vliagoftis H. et al. Connexin 43 expression on peripheral blood eosinophils: role of gap junctions in transendothelial migration. Biomed Res Int 2014; 2014: 803257.
• 108 Véliz LP. et al. Functional role of gap junctions in cytokine-induced leukocyte adhesion to endothelium in vivo. Am J Physiol Heart Circ Physiol 2008; 295: H1056-1066.
• 109 Chadjichristos CE. et al. Endothelial-specific deletion of connexin40 promotes atherosclerosis by increasing CD73-dependent leukocyte adhesion. Circulation 2010; 121: 123-131.
• 110 Thompson LF. et al. Crucial role for ecto-5-’ nucleotidase (CD73) in vascular leakage during hypoxia. J Exp Med 2004; 200: 1395-1405.
• 111 Eckle T. et al. Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. J Immunol 2007; 178: 8127-8137.
• 112 Volmer JB. et al. Ecto-5’-nucleotidase (CD73)-mediated adenosine production is tissue protective in a model of bleomycin-induced lung injury. J Immunol 2006; 176: 4449-4458.
• 113 Tiwari RL. et al. Macrophages: an elusive yet emerging therapeutic target of atherosclerosis. Med Res Rev 2008; 28: 483-544.
• 114 Abed A. et al. Targeting connexin 43 protects against the progression of experimental chronic kidney disease in mice. Kidney Int 2014; 86: 768-779.
• 115 Kreisel D. et al. In vivo two-photon imaging reveals monocyte-dependent neutrophil extravasation during pulmonary inflammation. Proc Natl Acad Sci USA 2010; 107: 18073-18078.
• 116 Eugenin EA. et al. TNF-alpha plus IFN-gamma induce connexin43 expression and formation of gap junctions between human monocytes/macrophages that enhance physiological responses. J Immunol 2003; 170: 1320-1328.
• 117 Westphalen K. et al. Sessile alveolar macrophages communicate with alveolar epithelium to modulate immunity. Nature 2014; 506: 503-506.
• 118 Donati A. et al. From macrohemodynamic to the microcirculation. Crit Care Res Pract 2013; 2013: 892710.
• 119 Sakr Y. et al. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004; 32: 1825-1831.
• 120 Dyson A, Singer M. Animal models of sepsis: Why does preclinical efficacy fail to translate to the clinical setting?. Crit Care Med 2009; 37: S30-37.
• 121 Spray DC. et al. Gap junctions and Bystander Effects: Good Samaritans and executioners. Wiley Interdiscip Rev Membr Transp Signal 2013; 02: 1-15.
• 122 Montero TD, Orellana JA. Hemichannels: new pathways for gliotransmitter release. Neuroscience 2015; 286: 45-59.
• 123 Davidson JO. et al. A key role for connexin hemichannels in spreading ischemic brain injury. Curr Drug Targets 2013; 14: 36-46.
• 124 Losa D. et al. Connexins as therapeutic targets in lung disease. Expert Opinion on Therapeutic Targets 2011; 15: 989-1002.
• 125 De Bock M. et al. Low extracellular Ca2+ conditions induce an increase in brain endothelial permeability that involves intercellular Ca2+ waves. Brain Res 2012; 1487: 78-87.
• 126 Parthasarathi K. Endothelial connexin43 mediates acid-induced increases in pulmonary microvascular permeability. Am J Physiol Lung Cell Mol Physiol 2012; 303: L33-42.
• 127 Kandasamy K. et al. Changes in endothelial connexin 43 expression inversely correlate with microvessel permeability and VE-cadherin expression in endotoxin-challenged lungs. Am J Physiol Lung Cell Mol Physiol 2015; 309: L584-592.
• 128 Zhang J. et al. Role of connexin 43 in vascular hyperpermeability and the relationship to the Rock 1-MLC20 pathway in septic rats. Am J Physiol Lung Cell Mol Physiol 2015; 309: L1323-1332.
• 129 Reaume AG. et al. Cardiac malformation in neonatal mice lacking connexin43. Science 1995; 267: 1831-1834.
• 130 Eckardt D. et al. Functional role of connexin43 gap junction channels in adult mouse heart assessed by inducible gene deletion. J Mol Cell Cardiol 2004; 36: 101-110.
• 131 Liao Y. et al. Endothelial cell-specific knockout of connexin 43 causes hypotension and bradycardia in mice. Proc Natl Acad Sci USA 2001; 98: 9989-9994.
• 132 Theis M. et al. Endothelium-specific replacement of the connexin43 coding region by a lacZ reporter gene. Genesis 2001; 29: 1-13.
• 133 Liao Y. et al. Smooth muscle-targeted knockout of connexin43 enhances neointimal formation in response to vascular injury. Arterioscl Thromb Vasc Biol 2007; 27: 1037-1042.
• 134 Nguyen TD, Taffet SM. A model system to study Connexin 43 in the immune system. Mol Immunol 2009; 46: 2938-2946.
• 135 Simon AM. et al. Mice lacking connexin40 have cardiac conduction abnormalities characteristic of atrioventricular block and bundle branch block. Curr Biol 1998; 08: 295-298.
• 136 Simon AM. et al. Female infertility in mice lacking connexin 37. Nature 1997; 385: 525-529.
• 137 Fang JS. et al. Cx37 deletion enhances vascular growth and facilitates ischemic limb recovery. Am J Physiol Heart Circ Physiol 2011; 301: H1872-1881.
• 138 Simon AM, McWhorter AR. Vascular abnormalities in mice lacking the endothelial gap junction proteins connexin37 and connexin40. Dev Biol 2002; 251: 206-220.
• 139 Iyyathurai J. et al. Peptides and peptide-derived molecules targeting the intracellular domains of Cx43: Gap junctions versus hemichannels. Neuropharmacology 2013; 75: 491-505.